Filing Flows › Kewaunee Scientific (KEQU) › Q1 FY27 › vs Q1 FY26
Kewaunee Scientific (KEQU) Q1 FY27 vs Q1 FY26 (year over year)
Kewaunee Scientific's revenue fell $4.8M (-7%) from $71.1M in Q1 FY26 to $66.3M in Q1 FY27. Gross margin 29.6% against 29.4% (+0.2 pts).
Kewaunee Scientific, Q1 FY27: revenue $66.3M (-7% year over year), operating margin 4.8%, net earnings $1.7M, operating cash flow $2.0M. The chart draws each line against Q1 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Gross margin | 29.6% | 29.4% | +0.2 pts |
| Operating margin | 4.8% | 6.8% | -2.0 pts |
| Net margin | 2.6% | 4.3% | -1.8 pts |
| Free cash flow margin | 1.8% | 7.1% | -5.2 pts |
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $66.3M | $71.1M | −$4.8M | -7% |
| Gross profit | $19.6M | $20.9M | −$1.3M | -6% |
| Cost of revenue | $46.7M | $50.2M | −$3.5M | -7% |
| Operating profit | $3.2M | $4.8M | −$1.7M | -34% |
| Operating expenses | $16.5M | $16.1M | $361K | +2% |
| Pre-tax earnings | $2.6M | $3.9M | −$1.4M | -35% |
| Other expense, net | $598K | $890K | −$292K | -33% |
| Net earnings | $1.7M | $3.1M | −$1.4M | -45% |
| Minority interests | $137K | $66K | $71K | +108% |
| Income tax | $717K | $761K | −$44K | -6% |
| Operating cash sources | $5.2M | $5.2M | $33K | +0.6% |
| Depreciation | $1.6M | $1.5M | $42K | +3% |
| Share-based compensation | $1.9M | $521K | $1.4M | +264% |
| Working capital & other | $3.2M | −$628K | $3.8M | — |
| Operating cash flow | $2.0M | $5.8M | −$3.8M | -66% |
| Free cash flow (OCF − capex) | $1.2M | $5.0M | −$3.8M | -76% |
| Capital expenditures | $772K | $771K | $1K | +0.1% |
Questions
How much did Kewaunee Scientific's revenue grow year over year in Q1 FY27?
Kewaunee Scientific's revenue fell $4.8M (-7%) from $71.1M in Q1 FY26 to $66.3M in Q1 FY27. Gross margin 29.6% against 29.4% (+0.2 pts).